CLOV might reverse from here We could see $10-$11 zone in a couple of days. might reverse from this point. triangle broke out todayLongby T2Run6
Support being tested Not financial advice, Check the previous post for updated comments.by TheChartHub0
Time for a reversal after weeks of bearsThe pace is slow into a bearish trend for weeks but price action does show some support above the weekly support. Watching if it can hold the 4H support for confirmed double bottom and break above the key s/r. by TheChartHubUpdated 663
W with double bottomas long as it holds the bottom, i see a strong reversal coming. Longby LetsBeMillionaire9
CLOV trading sideways. CLOV has been hit hard with the false short seller report, and couple that with the market conditions recently this stock is way undervalued. We bounced off support and it seems now that we are trading sideways after a small move up. RSI looks steady wanting to head high towards the overbought territory. MACD is in the green and it looks like it wants to widen greener. This is long hold for me and have no problem scooping up more shares at these prices. In Chammath we trust. Longby Dc13924
CLOV Post Earnings Bounce PlayThere are many reasons to favor a CLOV long position here with earnings on March 1, 2021. 1. We have wicked off the same bottoming zone explored last November. This has many characteristics of a capitulation wick after the rapid descent following news of the DOJ investigation. 2. Short interest on this stock is quite high, although reliable up-to-date information is hard to find but nonetheless appears to be fairly high (30%), and RSI appears oversold. 3. The options market is skewed towards puts - putting the max pain point between 12.50 and 15 - more than 25% above current levels. swaggystocks.com 4. CLOV's 50% decline into earnings fits the Goldman empirical earnings system quite well which shows that stocks declining into earnings tend to pop after earnings - generating an average of 18% call option returns vs 4% for all other stocks post earnings. 5. It appears that the decline in stock price is solely due to news surrounding a DOJ investigation rather than trend changes in the business or market. The history of TSLA and FB stock suggests that legal-related FUD is often transitory, as opposed to market/moat-related FUD. 6. Finally, technical factors favor a bounce in the overall market in the coming days, and today's 8% drop in CLOV accompanied a dramatic but failed selloff in the S&P 500 (see VVIX divergence mentioned in analysis below) Lastly, for those more concerned about the DOJ investigation than the charts or technicals, consider that the investigation began before the recent transition in the Executive Branch, and Chelsea Clinton - Vice Chair of the Clinton Foundation - serves on Clover's Board of Directors. For reasons completely outside technical analysis, it would appear that serious indictments by the DOJ are highly unlikely due to political reasons. investors.cloverhealth.com Just consider this like any other transitory FUD and take advantage of buying opportunities found in the charts - as you would with Bitcoin, Tesla, or similar assets. In addition to the shares I purchased yesterday, I purchased $10 call options March 19 ($1.05) and a 12.50 LEAP (June dated). Longby dtingbudongUpdated 111
Clover Health Will Show A Technical Growth In Channel To $9.92After a false breakout due to a correction in the broader market, $CLOV has re-entered the falling channel it has broken out of and closed within it. From this area, I expect growth towards the resistance zone around $9.92 to $10.00. However, do note that this zone of resistance that we are heading for is a very strong area of resistance. In this area, we see an intersection of: 1. Dynamic resistance created by the upper parallel line of the falling channel 2. Fibonacci resistance and Horizontal resistance 3. Former $10 SPAC price floor which acts as a very strong psychological resistance Regardless, I expect a move towards it first. Would have to see how the market reacts to this level first before deciding on our next course of action. This is not an investment or trading advice so please do your own due diligence! Support this idea with likes and share your thoughts below.Longby AntrePoint116
Clover Health Continues To Track The Broader Market Very CloselySince the market started selling-off late February due to disturbance in the bond market, the movements of $CLOV has since been mirroring the direction of the overall market relatively tightly. With the closing of the market earlier today after a considerably sideway and mixed trading day, S&P 500 rose by 0.60%, NASDAQ fell by 0.04%, while Dow Jones Industrial Average rose by 1.46%. Similarly, $CLOV also had a relatively mixed trading day, showing green for the first half of the trading session, and later closing slightly red on the second half. These movements can be attributed to the general market condition as well, where during the first half of the trading session, the release of bullish CPI data edged the market higher, while a relatively average and within expectations $38 billion 10-year notes auction brought the action back down to trade relatively sideway. I expect $CLOV to continue tracking the overall direction of the market closely, at least for tomorrow, where we await for the result of a $24 billion sale of 30-year bond that can potentially move the market significantly in either direction, should anything unexpected occur. Regardless, it is good to note that on a technical perspective, $CLOV is approaching some key trading area that we need to take note of. We are currently resting just below the dynamic resistance formed by the bottom of the previous bearish channel that were trading in before this bond-induced market correction. While we may have already rejected this area once (likely due to the broader market movement as mentioned above), if we are able to break back into the bearish channel, our next target would be the next Fibonacci resistance and the top of the aforementioned bearish channel at around $9.92. However, if we fail to break back into it, we could be looking at a re-test of $7.78 or even $6.67. As such, tomorrow's trading session will likely be a very important one as it will give us an indication of where we are headed short-term. Invest safe. This is not investment advice so please do your own due diligence! Support this idea with likes and share your thoughts below.Longby AntrePoint4
CLOV bullish reversalAfter seeing a double top in January, CLOV seems to have found its lowest level of support around $6.28 per share. Analysts have a price target around $13-$15 per share, which is very reasonable based on Fib retracement. Furthermore, on the daily chart, we see the MACD converging back up toward the signal, with the RSI 14 back on the rise now, from bottoming out at about 26. by StephenBinkley2
be careful herethis is why i dont trade recent IPOs, half of them are pumped and dumped by huge groups and leave the little guy holding a fat bag. dont be surprised if we see a test of 1-2 in the future. ugly! trade safe guysShortby Vibranium_Capital2222
$CLOV Found support and is bouncing$CLOV has allot of positive in this chart. Consolidating within support. Mac D crossover. Falling wedges are bullish. Buy the breakout of the trendline.Longby TheStockWhisper5
CLOV 4 hourlycoming out of oversold territory. Resistance areas to watch for- $8, 8.5, 9.4. Longby William_Blake222
CLOV 4 hourlycoming out of oversold area. Resistance areas to watch $8, 8.5, and 9.4 .Longby William_Blake111
Clover Health Rallies Despite An Early Sell-off Into A $6.31 LowThe movement of $CLOV continues to mirror the condition of the overall market. Today, the tech-led sell-off took a pause, with S&P 500 rising by 1.95% and NASDAQ Composite rising by 1.55%. Similarly, Clover Health ended higher by 7.54%, closing above the previous day's close. Going into next week, I expect $CLOV performance to continue reflecting the overall market condition. Nevertheless, these are some notable resistance and support area that you should take note next week, with key areas highlighted in Bold: Psychological resistance: $8.00 , $8.50 , $9.00 Psychological support: $7.50, $7.00, $6.50 , $6.00 Fibonacci resistance: $9.92 Fibonacci support: $7.78, $6.67 , $5.07 Dynamic resistance: Bottom of the previous bearish channel that we were trading in before this market correction ( ~$8.50 ) Dynamic support: Top of the very tight bearish channel that we just broke out of (~$7.10) Once this correction is over, I expect $CLOV to emerge as one of the winners. Invest safe. This is not investment advice so please do your own due diligence! Support this idea with likes and share your thoughts below.Longby AntrePoint665
CLOV hype is overmany twitter pumpers pumped this stock. was incredibly hyped. looking for it to die out soon. could see push to around 5. weatching the RSI too to get a potential entry long,by Jack0Updated 110
CLOV at supportIf you have followed me then you know the drill. Looks like CLOV has reached its support. Bullish divergence and bull volume coming in at the lows. Buy and Hold. Longby Stock_Holiday86Updated 1
CLOVLONG-TERM: Bullish crab pattern, the idea here is to scale in by cost averaging ,as there are two potential PCZ's, first one at $7 and second one at $6.35. Also trying to paint a 4hr hammer candle, classic bullish divergence is possible eventually. (not financial advice)Longby Champion-Vibe119
$CLOV Potential CrabIf this freefall continues we could see a similar pattern as UWMC just had. Depending on where you place point X the PRZ can be either the top or bottom of the purple box. If we see a bounce in this zone that could be the potential entry point. High risk high reward.Longby GuyInHat1
$CLOV Finding The BottomThe bearish channel has broken to the downside and we are now in an unchartered territory. Within this unchartered territory, I expect every $0.50 to be a new support (i.e. $8.50, $8.00, $7.50, $7.00, and so on). As of the time that I am writing this post, we have broken the $8.50 support and found a $8.03 low. It will be difficult to predict where we will find a bottom, but what I can tell you is that $CLOV is severely undervalued at this price. It was undervalued at $10, it is undervalued at $8.00, and it will still be undervalued if it dips below $8.00. $CLOV recent earnings, albeit slower than expected, has proved that it is capable of growth. This will be a winner further down the road. However, if you are in this for a quick buck, $CLOV is not for you. But if you are an investor, do your fullest DD, strengthen your resolves, and buckle your seatbelts, because you are in for a rollercoaster ride until the negative sentiment surrounding $CLOV settles down. Regardless, $CLOV will be a winner for long-term investors. Chamath Palihapitiya once said in a CNBC interview that Clover Health will be their next 10x in 10 years investment, and I truly believe $CLOV is capable of it. This is not investment advice so please do your own due diligence! Support this idea with likes and share your thoughts below.Longby AntrePoint3
CLOV Retracement, Massively Oversold but Needs PRCLOV has not received much love these past few weeks after the short report from Hindenburg came out, but I believe that the short report does not hold much substance as well as the fact that CLOV had posted phenomenal earnings. CLOV stock had dropped about 12% after reporting great earnings but weak guidance for 2021. CLOV is also being investigated by the DOJ due to the short report which has created a lot of uncertainty for the stock. But all of these variables do not discredit the fact that CLOV has been massively beaten down along with having great earnings. I see CLOV most likely trading sideways until the DOJ investigation is over. Any type of good PR for CLOV will send the stock skyrocketing with immense upside, but if the DOJ investigation materializes into anything, CLOV's stock price might be sent down into the 5s. Key support for CLOV is 9$ and then 8.50$. My prediction for CLOV is it having a short-term spike up to 9.70$ then bottoming out in the low 9s. This is not financial advice, I am not advocating the buying or selling of CLOV stock.Longby kediguy1
$CLOV Earnings OutlookFrom 2019 to 2020, $CLOV posted a total revenue growth from $462.3M to $672.9M, net premium revenue growth from $456.9M to $665.7M, decrease in net loss from -$363.7M to -$91.6M, and a decrease in adjusted EBITDA loss from -$175.5M to -$74.4M, among others. $CLOV also saw a 36.3% increase in membership and a 43.2% year-over-year increase in lives under Clover Assistant management to 58,056 membership and over 32,400 lives respectively. For full year 2021 guidance, $CLOV stated a total revenue expectation of $820M to $850M, net loss expectation of -$210M to -$170M, adjusted EBITDA loss expectation of -$190M to -$150M, loss per share of -$0.52 to -$0.42. Furthermore, they are also expecting a 17% to 21% growth in Medicare Advantage membership to 68,000 to 70,000 membership compared to year end 2020's 58,056. Based on the above full year 2020 financial results and full year 2021 guidance reported by Clover Health, I believe it puts us somewhere in the middle of our bear case and base case as said according to our last $CLOV Bear Base Bull outlook, which you can re-visit by looking at the related idea below. In my opinion, despite being off-target, the financial and membership growth that they have posted from 2019 to 2020 has demonstrated their ability to deliver growth, proven the scalability of their business model, and reaffirmed Chamath Palihapitiya statement of $CLOV having a predictable growth model. However, I believe they have shot themselves in their foot with the full year 2021 guidance. Based on the figures they have posted, it tells me that they are expecting a slowdown in growth compared to what they have experienced from 2019 to 2020. This will not be viewed kindly by investors and Wall Street. Going forward, I expect $CLOV to continue trading within the bearish channel, within the range of $8.50 to $10.50. Unless further positive catalyst appears, I do not see $CLOV breaking above the bearish channel yet. Nevertheless, in an environment where many SPAC and companies are trading at a massive speculative values, I see $CLOV being valued realistically at the moment and trading at a realistic price. Once given enough time to play out the growth that $CLOV is currently building, it will be a long-term winner. TLDR: Short-term: Underperform with a trading range of $8.50 to $10.50 unless more positive catalyst appears, Mid/Long-term: Easily >2x from current price. This is not investment advice so please do your own due diligence! Support this idea with likes and share your thoughts below.Longby AntrePoint775